Dr. Suzanne M. Miller is a Professor at Fox Chase Cancer Center in the department of Cancer Prevention and Control. She earned her PhD in Clinical Psychology at the Institute of Psychiatry, Maudsley Hospital, University of London.

Guided by the Cognitive-Social Health Information Processing (C-SHIP) model, the overarching goal of Dr. Miller's lab is to make cancer prevention-control programs more effective by assessing and addressing the distinctive ways in which individuals make decisions, adjust to risk information, manage recommended medical regimens, as well as survivorship issues. Specifically, the focus is on interventions to enhance decision-making for prevention, treatment and clinical trial options; adherence to recommended screening, prevention and treatment regimens; adjustment to cancer risk feedback; and the translation and dissemination of interventions into clinical, community and other service settings and systems.

The lab employs a transdisciplinary/cross-institutional team approach in designing, developing and evaluating both traditional (e.g., print materials, telephone counseling interventions) and new technology (e.g., text-messaging, web-based applications) tailored to individual differences and targeted to social determinants of health among patients and their families. Dr. Miller’s role as Editor-in-Chief of The Journal of Translational Behavioral Medicine afforded her the platform to help shape the field of implementation science and the implications for practice and policy.

Dr. Miller’s team have researched and developed interventions for patients across the cancer care continuum (e.g., prevention, treatment decision making, treatment management, survivorship care) and across various disease sites (e.g., cervical, prostate, bladder, kidney, ovarian, and breast). Additionally, she has recently received funding to evaluate the perspectives of underinsured patients on the impact of co-pay assistance on financial toxicity, including their quality of life and behavioral health.

Dr. Miller's most recent NCI and foundation grant funded research has focused on developing and evaluating interventions designed to:

• Enhance decision making about preference-sensitive cancer screening and treatment options, specifically among early-stage prostate and kidney cancer patients
• Increase adherence to follow up cervical cancer diagnostic screening following an abnormal Pap smear among minoritized women
• Promote long-term smoking cessation among underserved pregnant and postpartum women through text messaging and coaching